APA
Chen G., Wei L., Chen J., Duan Z., Dou X., Xie Q., Zhang W., Lu L., Fan J., Cheng J., Wang G., Ren H., Wang J., Yang X., Jia Z., Fu Q., Wang X., Shang J., Zhang Y., Han Y., Du N., Shao Q., Ji D., Li F., Li B., Liu J., Niu X., Wang C., Wu V., Wong A., Wang Y., Hou J., Jia J., Zhuang H. & Lau G. (20170714). Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. : PloS one.
Chicago
Chen Guo-Feng, Wei Lai, Chen Jing, Duan Zhong-Ping, Dou Xiao-Guang, Xie Qing, Zhang Wen-Hong, Lu Lun-Gen, Fan Jian-Gao, Cheng Jun, Wang Gui-Qiang, Ren Hong, Wang Jiu-Ping, Yang Xing-Xiang, Jia Zhan-Sheng, Fu Qing-Chun, Wang Xiao-Jin, Shang Jia, Zhang Yue-Xin, Han Ying, Du Ning, Shao Qing, Ji Dong, Li Fan, Li Bing, Liu Jia-Liang, Niu Xiao-Xia, Wang Cheng, Wu Vanessa, Wong April, Wang Yu-Dong, Hou Jin-Lin, Jia Ji-Dong, Zhuang Hui and Lau George. 20170714. Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. : PloS one.
Harvard
Chen G., Wei L., Chen J., Duan Z., Dou X., Xie Q., Zhang W., Lu L., Fan J., Cheng J., Wang G., Ren H., Wang J., Yang X., Jia Z., Fu Q., Wang X., Shang J., Zhang Y., Han Y., Du N., Shao Q., Ji D., Li F., Li B., Liu J., Niu X., Wang C., Wu V., Wong A., Wang Y., Hou J., Jia J., Zhuang H. and Lau G. (20170714). Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. : PloS one.
MLA
Chen Guo-Feng, Wei Lai, Chen Jing, Duan Zhong-Ping, Dou Xiao-Guang, Xie Qing, Zhang Wen-Hong, Lu Lun-Gen, Fan Jian-Gao, Cheng Jun, Wang Gui-Qiang, Ren Hong, Wang Jiu-Ping, Yang Xing-Xiang, Jia Zhan-Sheng, Fu Qing-Chun, Wang Xiao-Jin, Shang Jia, Zhang Yue-Xin, Han Ying, Du Ning, Shao Qing, Ji Dong, Li Fan, Li Bing, Liu Jia-Liang, Niu Xiao-Xia, Wang Cheng, Wu Vanessa, Wong April, Wang Yu-Dong, Hou Jin-Lin, Jia Ji-Dong, Zhuang Hui and Lau George. Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. : PloS one. 20170714.